Published in Vaccine Weekly, July 7th, 1997
Havrix is the only vaccine specifically licensed for active immunization against the hepatitis A virus in chronic liver disease patients. It is estimated that more than 5 million Americans are currently living with one or more of the diseases collectively classified as chronic liver disease, including alcoholic cirrhosis, chronic hepatitis B, chronic hepatitis C, autoimmune...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.